Schedule 13D ownership disclosure

Brickell Biotech, Inc.

Security class unavailable · CUSIP: 10802T105

Event date: 2020-09-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,073,374
Percent of class
3.8600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-108288
Form type
SC 13D/A
Filer
Fresh Tracks Therapeutics, Inc.
CIK
CIK 819050
Filed
Sep 24, 2020
Reporting period
Sep 14, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub